Why doctors analyze patients who never actually took the medicine
In short: In clinical trials, some patients drop out or refuse treatment. If researchers only studied those who finished the course, they might see a fake success. To find the truth, scientists use a method that counts everyone originally assigned to a group, preserving the integrity of the initial random shuffle.
The gold standard for establishing causality is the randomized controlled trial (RCT). Randomization works by balancing known and unknown variables between two groups, ensuring that any difference in outcome can be attributed to the intervention rather than pre-existing differences. However, this balance is fragile; if researchers only analyze patients who strictly followed the protocol—a method called 'per-protocol' analysis—they risk introducing significant bias.
Consider a hypothetical study of 200 cardiovascular patients where surgery is added to medical therapy. If 15 patients in the surgery group die before they can even reach the operating table, a per-protocol analysis would exclude them from the surgery data. This could make the surgery appear more effective than it truly is because the 'weakest' patients were removed from the denominator. Intention-to-treat (ITT) analysis solves this by including every patient based on their original random assignment, regardless of whether they received the treatment, dropped out, or switched groups.
ITT provides an unbiased estimate of a treatment policy's effectiveness in the real world, where adherence is rarely perfect. It prevents 'non-random attrition,' such as patients with more severe symptoms dropping out due to side effects. While ITT is simpler because it doesn't require tracking every dose, it faces challenges with missing data. Some researchers use 'modified intention-to-treat' (mITT) to handle these gaps, though some literature links this practice to potential conflicts of interest or industry sponsorship.
The goal of ITT is to preserve the prognostic balance afforded by randomization throughout the entire study. By analyzing patients as they were intended to be treated, investigators can draw accurate conclusions about how a medical intervention will perform in a general population where people often miss doses or experience complications.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Understanding the Intention-to-treat Principle in Randomized Controlled Trials
- Also: Intention-to-treat analysis
To cite this card, link to https://intellectplus.co.uk/app/health-intention-to-treat-analysis.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Epidemiology · More in Health · Latest · A–Z · All topics
